Prevalence of Catastrophic and Impoverishing Health Expenditures and Potential Protection against Financial Risks through Subsidies in Guinea
No hay miniatura disponible
Fecha
Título de la revista
ISSN de la revista
Título del volumen
Editor
World Bank, Washington, DC
Resumen
Descripción
Universal health coverage initiatives
in Guinea have been hampered by insufficient budget
allocations and inefficiencies. Nevertheless, data on the
extent of catastrophic and impoverishing health expenditures
in Guinea are scarce and outdated. The objectives of this
study were to (1) identify the drivers of total health
expenditures, (2) estimate the prevalence of catastrophic
and impoverishing health expenditures, and (3) estimate the
drivers of and potential financial risk protection against
catastrophic and impoverishing health expenditures through
subsidies in Guinea. A retrospective cohort study was
conducted using the 2018–19 Guinea Living Standards
Measurement Study. All 41,449 individuals in the Study were
eligible, but 15 individuals who lacked consumption
expenditure data were excluded. Expenditure data were
converted to 2019 international dollars. Based on means and
medians, the primary drivers of total health expenditures
were hospitalizations ($78 and $51, respectively) and
medications ($72 and $61, respectively). Based on the
distribution of total health expenditures by expenditure
categories, the primary driver was medications (75 percent).
The main driver of hospitalization expenditures was fever
and malaria (21 percent of hospitalization expenditures).
The prevalences of catastrophic and health expenditures
(equal to or greater than 10 percent threshold) and
impoverishing health expenditures were 13 and 4 percent,
respectively. Subsidizing medications would prevent 46
percent of the cases of catastrophic health expenditures and
73 percent of the cases of impoverishing health
expenditures. It is recommended that the Guinean government
(1) strengthen the country’s pharmaceutical sector by
reinforcing existing laws and regulations and the
operational aspects of the sector; (2) implement subsidy
programs for rational use of medicines (notwithstanding the
Bamako Initiative); (3) strengthen the National Malaria
Control Program; and (4) establish an evidence-based
operational financing strategy for universal health coverage.
Palabras clave
UNIVERSAL HEALTH COVERAGE (UHC), CATASTROPHIC HEALTH EXPENDITURE, IMPOVERISHING HEALTH EXPENDITURES, FINANCIAL RISK PROTECTION, BAMAKO INITIATIVE, PRESCRIPTION SUBSIDY
